Demis Hassabis, DeepMind CEO (Qianlong/Imaginechina via AP Images)
Updated: DeepMind's AlphaFold now contains structure of 200M proteins. What does that mean for drug R&D?
When AlphaFold first came out, it debuted with the promise of increasing the number of protein structures that could be predicted, a move that had …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
